Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$101.21 - $166.61 $139,062 - $228,922
-1,374 Reduced 41.47%
1,939 $230,000
Q1 2024

May 01, 2024

BUY
$85.37 - $115.44 $45,758 - $61,875
536 Added 19.3%
3,313 $353,000
Q4 2023

Feb 01, 2024

SELL
$69.51 - $104.43 $502,418 - $754,820
-7,228 Reduced 72.24%
2,777 $276,000
Q3 2023

Nov 06, 2023

SELL
$96.41 - $126.61 $147,314 - $193,460
-1,528 Reduced 13.25%
10,005 $1.03 Million
Q2 2023

Aug 01, 2023

BUY
$118.5 - $160.53 $16,234 - $21,992
137 Added 1.2%
11,533 $1.4 Million
Q1 2023

May 05, 2023

SELL
$135.66 - $197.02 $91,027 - $132,200
-671 Reduced 5.56%
11,396 $1.75 Million
Q4 2022

Jan 24, 2023

BUY
$118.38 - $210.04 $75,644 - $134,215
639 Added 5.59%
12,067 $0
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $10,508 - $17,282
-89 Reduced 0.77%
11,428 $1.35 Million
Q2 2022

Aug 11, 2022

BUY
$117.13 - $176.59 $5,387 - $8,123
46 Added 0.4%
11,517 $1.65 Million
Q1 2022

Apr 20, 2022

SELL
$126.46 - $235.05 $69,426 - $129,042
-549 Reduced 4.57%
11,471 $1.98 Million
Q4 2021

Feb 02, 2022

SELL
$225.82 - $368.51 $3.43 Million - $5.59 Million
-15,178 Reduced 55.81%
12,020 $3.05 Million
Q3 2021

Oct 28, 2021

BUY
$221.9 - $484.47 $3.1 Million - $6.77 Million
13,973 Added 105.66%
27,198 $10.5 Million
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $51,574 - $93,287
397 Added 3.09%
13,225 $3.11 Million
Q1 2021

May 06, 2021

SELL
$109.18 - $185.98 $44,545 - $75,879
-408 Reduced 3.08%
12,828 $1.68 Million
Q4 2020

Feb 09, 2021

SELL
$65.74 - $169.86 $253,887 - $655,999
-3,862 Reduced 22.59%
13,236 $1.38 Million
Q3 2020

Nov 03, 2020

SELL
$54.34 - $94.85 $55,155 - $96,272
-1,015 Reduced 5.6%
17,098 $1.21 Million
Q2 2020

Jul 31, 2020

BUY
$29.67 - $80.0 $236,113 - $636,640
7,958 Added 78.37%
18,113 $1.16 Million
Q1 2020

May 01, 2020

BUY
$17.78 - $31.58 $180,555 - $320,694
10,155 New
10,155 $304,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.